用胃肠外途径给予克林霉素治疗严重拟杆菌感染。
Treatment of severe bacteroides infections with parenteral clindamycin.
作者信息
Haldane E V, Van Rooyen C E
出版信息
Can Med Assoc J. 1972 Dec 23;107(12):1177-81.
Abstract
Clindamycin, by intravenous or intramuscular administration, was used in the treatment of 18 patients seriously ill with infections due to bacteroides organisms. In 17 cases there was a rapid favourable clinical response to treatment. No serious toxic effects were observed. This study appears to confirm previous in vitro evidence that clindamycin is presently the antibiotic of choice for such infections.
摘要
通过静脉或肌肉注射给予克林霉素，用于治疗18例因拟杆菌属微生物感染而病情严重的患者。17例患者对治疗有迅速良好的临床反应。未观察到严重的毒性作用。本研究似乎证实了先前的体外证据，即克林霉素目前是此类感染的首选抗生素。
相似文献
1
Treatment of severe bacteroides infections with parenteral clindamycin.
Can Med Assoc J. 1972 Dec 23;107(12):1177-81.
2
Treatment of Bacteroides infection with clindamycin-2-phosphate.
Can Med Assoc J. 1974 Nov 2;111(9):945-7, 949.
3
Treatment of anaerobic infections with lincomycin and clindamycin.
N Engl J Med. 1972 Nov 16;287(20):1006-10. doi: 10.1056/NEJM197211162872002.
4
Treatment of Bacteroides fragilis bacteremia with clindamycin.
J Infect Dis. 1973 Oct;128(4):569-71. doi: 10.1093/infdis/128.4.569.
5
[Therapy for severe anaerobic infections with clindamycin (author's transl)].
Jpn J Antibiot. 1977 Jan;30(1):13-21.
6
High-dose tobramycin combined with clindamycin or lincomycin in the treatment of septic peritonitis and intraabdominal sepsis.
Acta Chir Scand. 1981;147(5):339-46.
7
Lincomycins in the treatment of bacteroides infections.
Br Med J. 1972 Jan 29;1(5795):280-2. doi: 10.1136/bmj.1.5795.280.
8
Bacteroides infections.
Ann Surg. 1973 May;177(5):601-6.
9
Parenteral clindamycin therapy for severe anaerobic infections.
Arch Intern Med. 1974 Jul;134(1):78-82.
10
Clindamycin and lincomycin: oral and parenteral therapy.
JAMA. 1977 Apr 4;237(14):1482-4.
引用本文的文献
1
Antimicrobial susceptibilities of anaerobic bacteria: recent clinical isolates.
Antimicrob Agents Chemother. 1974 Sep;6(3):311-5. doi: 10.1128/AAC.6.3.311.
2
Speed of bactericidal action of penicillin G, ampicillin, and carbenicillin on Bacteroides fragilis.
Antimicrob Agents Chemother. 1974 Sep;6(3):227-31. doi: 10.1128/AAC.6.3.227.
3
Chemotherapy of an experimental Fusobacterium (Sphaerophorus) necrophorum infection in mice.
Antimicrob Agents Chemother. 1974 Jun;5(6):658-62. doi: 10.1128/AAC.5.6.658.
4
Prospective, randomized, double-blind comparison of metronidazole and tobramycin with clindamycin and tobramycin in the treatment of intra-abdominal sepsis.
Ann Surg. 1980 Aug;192(2):213-20. doi: 10.1097/00000658-198008000-00015.
5
Treatment of Bacteroides infection with clindamycin-2-phosphate.
Can Med Assoc J. 1974 Nov 2;111(9):945-7, 949.
6
Treatment of anaerobic bacterial infections with clindamycin-2-phosphate.
Antimicrob Agents Chemother. 1974 Mar;5(3):276-80. doi: 10.1128/AAC.5.3.276.
7
Streptococcus bovis endocarditis.
Can Med Assoc J. 1974 Oct 5;111(7):678-9, 82.
8
Infectious diseases: annual review of significant publications.
Postgrad Med J. 1974 Aug;50(586):485-96. doi: 10.1136/pgmj.50.586.485.
9
Clindamycin phosphate in severe infections mainly caused by Bacteroides fragilis: clinical and microbiological evaluation.
Infection. 1974;2(2):59-63. doi: 10.1007/BF01642022.
10
Clindamycin plus gentamicin as expectant therapy for presumed mixed infections.
Can Med Assoc J. 1976 Dec 18;115(12):1225-9.
本文引用的文献
1
Bacteroides pneumonias. Characteristics of cases with empyema.
Ann Intern Med. 1968 Feb;68(2):308-17. doi: 10.7326/0003-4819-68-2-308.
2
The effect of carbon dioxide on the sensitivity of Bacteroides fragilis to certain antibiotics in vitro.
J Clin Pathol. 1970 Apr;23(3):254-8. doi: 10.1136/jcp.23.3.254.
3
Bactericidal activity of five antimicrobial agents against Bacteroides fragilis.
J Infect Dis. 1972 Jul;126(1):104-7. doi: 10.1093/infdis/126.1.104.
4
Lincomycins in the treatment of bacteroides infections.
Br Med J. 1972 Jan 29;1(5795):280-2. doi: 10.1136/bmj.1.5795.280.
5
Bacteroides bacteremia. Experience in a hospital for neoplastic diseases.
Cancer. 1972 Jan;29(1):245-51. doi: 10.1002/1097-0142(197201)29:1<245::aid-cncr2820290137>3.0.co;2-v.
6
In vitro antimicrobial susceptibility of anaerobic bacteria isolated from clinical specimens.
Antimicrob Agents Chemother. 1972 Feb;1(2):148-58. doi: 10.1128/AAC.1.2.148.
7
The susceptibility of Bacteroides fragilis to 24 antibiotics.
J Infect Dis. 1972 Mar;125(3):295-9. doi: 10.1093/infdis/125.3.295.
8
A study in vitro of the sensitivity to antibiotics of Bacteroides fragilis.
J Clin Pathol. 1968 Jul;21(4):432-6. doi: 10.1136/jcp.21.4.432.
9
Clinical and bacteriological studies with clindamycin.
Br Med J. 1970 Jun 20;2(5711):703-4. doi: 10.1136/bmj.2.5711.703.
Zotero 插件